Status:
COMPLETED
Opioid Free Anesthesia in Breast Cancer Surgery
Lead Sponsor:
Peking University People's Hospital
Conditions:
Opioid Free Anesthesia
Eligibility:
FEMALE
20-75 years
Phase:
NA
Brief Summary
A comparison of incidences of postoperative nausea and vomiting (PONV) , postoperative pain severity and recovery parameters in breast cancer patients receiving opioid or opioid-free general anesthesi...
Detailed Description
Breast cancer is one of the most common oncologic diagnosis in women. Surgery is traditionally performed under general anesthesia with opioid-based analgesia. It is associated with higher incidences o...
Eligibility Criteria
Inclusion
- first diagnosis of histologically confirmed primary breast cancer without known extension beyond the breast and axillary nodes;
- ASA physical statue I-II;
Exclusion
- chronic pain and opioid administration history;
- allergy to local anesthetics or NSAIDs;
- coagulation disorders;
- local infection at regional block site;
- unable to comply to study protocol schedule for logistic or other reasons;
- refusal to participate to the study；
- breast reconstruction with implants or latissimus dorsi flap
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04390698
Start Date
July 1 2020
End Date
March 15 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044